MedTrace Logo

Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Skin Cancer

NCT00747903 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2014-01-10

No results posted yet for this study

Summary

RATIONALE: Photodynamic therapy uses a drug that becomes active when it is exposed to a certain kind of light. When the drug is active, tumor cells are killed. This may be an effective treatment against skin cancer.

PURPOSE: This phase II trial is studying the side effects of photodynamic therapy using aminolevulinic acid and to see how well it works in treating patients with skin cancer.

Conditions

  • Non-melanomatous Skin Cancer

Interventions

DRUG

aminolevulinic acid hydrochloride

Sponsors & Collaborators

  • Laser and Skin Surgery Center of New York

    lead OTHER

Principal Investigators

  • Diana Santanello · Laser and Skin Surgery Center of New York

Study Design

Purpose
TREATMENT
Masking
NONE

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2010-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00747903 on ClinicalTrials.gov